Medium- and long-chain triglyceride propofol activates PI3K/AKT pathway and inhibits non-alcoholic fatty liver disease by inhibiting lipid accumulation-Reference-Cited by-同舟云学术

Medium- and long-chain triglyceride propofol activates PI3K/AKT pathway and inhibits non-alcoholic fatty liver disease by inhibiting lipid accumulation

Published:2023-11-30 Issue:1 Volume:56 Page:45-53
ISSN:0145-479X
Container-title:Journal of Bioenergetics and Biomembranes
language:en
Short-container-title:J Bioenerg Biomembr

Author:

Liu Hui,Hao Mingshuo,Liu Wen,Chen Haiyan,Han Changlong,Shao Yun,Wang Liyuan

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10863-023-09997-0.pdf

Reference29 articles.

1. Alves-Bezerra M, Cohen DE (2017) Triglyceride metabolism in the liver. Compr Physiol 8:1–8. https://doi.org/10.1002/cphy.c170012

2. Chen Z, Chen L, Sun B et al (2021) LDLR inhibition promotes hepatocellular carcinoma proliferation and Metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway. Mol Metabolism (Germany) 51:101230. https://doi.org/10.1016/j.molmet.2021.101230

3. Deprince A, Haas JT, Staels B (2020) Dysregulated lipid metabolism links NAFLD to Cardiovascular Disease. Mol Metab 42:101092. https://doi.org/10.1016/j.molmet.2020.101092

4. Dostert C, Grusdat M, Letellier E et al (2019) The TNF family of ligands and receptors: communication modules in the Immune System and Beyond. Physiol Rev 99:115–160. https://doi.org/10.1152/physrev.00045.2017

5. Fan Y, He Z, Wang W et al (2018) Tangganjian decoction ameliorates type 2 Diabetes Mellitus and nonalcoholic fatty Liver Disease in rats by activating the IRS/PI3K/AKT signaling pathway. Biomed Pharmacother 106:733–737. https://doi.org/10.1016/j.biopha.2018.06.089